Molecure S.A. (WSE:MOC)
Poland flag Poland · Delayed Price · Currency is PLN
5.95
+0.06 (1.02%)
Jul 24, 2026, 5:00 PM CET

Molecure Revenue

In the year 2025, Molecure had annual revenue of 6.52M PLN with 122.20% growth. Molecure had revenue of 2.59M in the quarter ending December 31, 2025, with 43.21% growth.

Revenue (ttm)
6.73M
Revenue Growth
+90.89%
P/S Ratio
18.80
Revenue / Employee
91.82K
Employees
71
Market Cap
122.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.52M3.59M122.20%
Dec 31, 20242.93M-738.15K-20.10%
Dec 31, 20233.67M-3.87M-51.29%
Dec 31, 20227.54M6.08M416.21%
Dec 31, 20211.46M-123.45M-98.83%
Dec 31, 2020124.91M122.88M6,039.22%
Dec 31, 20192.03M626.09K44.45%
Dec 31, 20181.41M-63.01K-4.28%
Dec 31, 20171.47M-146.99K-9.08%
Dec 31, 20161.62M612.55K60.89%
Dec 31, 20151.01M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIOTON266.02M
Ryvu Therapeutics88.38M
Synthaverse42.19M
Mabion17.61M
Urteste2.50M
Captor Therapeutics Spolka Akcyjna2.38M
Pharmena1.61M
Poltreg250.00K
Revenue Rankings

Molecure News

More News